Amgen
AMGN
1,735 hedge funds and large institutions have $99.9B invested in Amgen in 2017 Q4 according to their latest regulatory filings, with 235 funds opening new positions, 702 increasing their positions, 586 reducing their positions, and 88 closing their positions.
167% more first-time investments, than exits
New positions opened: 235 | Existing positions closed: 88
20% more repeat investments, than reductions
Existing positions increased: 702 | Existing positions reduced: 586
8% more funds holding
Funds holding: 1,606 → 1,735 (+129)
0.11% more ownership
Funds ownership: 79.07% → 79.17% (+0.11%)
7% less capital invested
Capital invested by funds: $108B → $99.9B (-$7.82B)
31% less funds holding in top 10
Funds holding in top 10: 88 → 61 (-27)
38% less call options, than puts
Call options by funds: $788M | Put options by funds: $1.28B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$195M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$146M |
| 3 |
D.E. Shaw & Co
New York
|
+$146M |
| 4 |
Goldman Sachs
New York
|
+$132M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$127M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.27B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$276M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$181M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$138M |
| 5 |
JP Morgan Chase
New York
|
-$115M |
AMGN Hedge Fund Activity: Q4 2017 in Review
1,735 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2017, worth a combined $99.9B — down 7.3% from $108B a quarter earlier.
Buyers outnumbered sellers: 235 funds opened new AMGN positions and 88 closed out — a net gain of 147 holders — while 702 added to existing stakes and 586 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $195M. The largest seller was Fidelity Investments, cutting an estimated $1.27B.
- 1,735 institutional investors held Amgen (AMGN) as of Q4 2017, up from 1,606 in Q3 2017.
- Funds reported $99.9B of Amgen stock for Q4 2017, down 7.3% quarter-over-quarter.
- 235 funds opened new Amgen positions in Q4 2017 and 88 closed out, a net change of +147 holders.
- The largest Amgen buyer in Q4 2017 was Amundi Asset Management US, an estimated $195M added.
- The largest Amgen seller in Q4 2017 was Fidelity Investments, an estimated $1.27B sold.
Based on aggregated 13F filings for Q4 2017.